
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
A
ABT
Abbott Laboratories
$109.56
-1.48 (-1.33%)
Summary
Stories
News
Metrics
Fundamentals
Current Market Valuation
Current Price
$109.56
Live market price
P/E (TTM)
15.58
EPS: $7.03
P/S (TTM)
5.86
Price to Sales
TTM Quarters
3
Quarters included in TTM
Updated: 3/8/2026, 10:24:12 PM
Historical Trends
Range:
Revenue Over Time
Net Income Over Time
Short Interest (% of Float) Over Time
Short Interest
17.2M
% of Float
1.0%
Days to Cover
1.5
Avg Daily Vol
11.4M
Historical income statement data up to 5 years
Historical SEC Filings
Report Period
Debt/Equity
0.25
Leverage ratio
ROE (TTM)
12.36%
Return on equity
Income Statement
Revenue
$44.33B
Cost of Revenue
$19.32B
Gross Profit
$25.01B
Operating Income
$8.05B
Net Income
$6.52B
EPS (Quarter)
$3.72
EPS (TTM)
--
Balance Sheet
Total Assets
$86.71B
Total Liabilities
$33.94B
Shareholders' Equity
$52.77B
Current Assets
$26.00B
Current Liabilities
$16.50B
Cash & Equivalents
--
Long-Term Debt
$12.93B
Cash Flow
Operating Cash Flow
$9.57B
Investing Cash Flow
$-2.42B
Financing Cash Flow
$-6.31B
Free Cash Flow
$7.14B
Profitability Margins
Gross Margin
56.42%
Operating Margin
18.17%
Net Profit Margin
14.72%
ROA (TTM)
7.52%
ROE (TTM)
12.36%
Data source: Polygon.io
Last updated: 3/8/2026, 10:24:12 PM
Company Profile
Symbol
ABT
Market Cap
$190.38B
IPO Date
Apr 19, 1949
CEO
Robert B. Ford
Employees
115,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
Read MoreSimilar Stocks
MRK
Merck & Co., Inc.
$115.79
-0.24%
BSX
Boston Scientific Corporation
$71.35
-2.25%
MDT
Medtronic plc
$90.90
-2.27%
DHR
Danaher Corporation
$195.50
-3.22%